Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Lymphedema 2Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × pycnogenols × Clear all
NCT00214032 2015-10-05

Pycnogenol for the Treatment of Lymphedema

University of Wisconsin, Madison

Phase 2 Completed
2 enrolled

Lymphedema

NCT00064857 2008-04-22

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
26 enrolled

Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡